Oklo Is Down 61% This Year Despite a Real Technical Milestone. Here's the Disconnect Between the Stock and the Science.

Impact · against what's priced in

The article provides no new catalysts for Oklo, as the technical milestones and regulatory hurdles mentioned are already reflected in the current valuation. The reported stock decline and the lack of a commercial NRC license are known factors that the market has already priced in.

OKLO+0.00

Already priced in

The price assumes

The successful achievement of first criticality at the Groves test reactor